A detailed history of Pnc Financial Services Group, Inc. transactions in Belite Bio, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 8 shares of BLTE stock, worth $460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$460
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$46.52 - $83.84 $372 - $670
8 New
8 $0

Others Institutions Holding BLTE

About BELITE BIO, INC


  • Ticker BLTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,867,400
  • Market Cap $1.43B
  • Description
  • Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...
More about BLTE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.